vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and VIRTUS INVESTMENT PARTNERS, INC. (VRTS). Click either name above to swap in a different company.
VIRTUS INVESTMENT PARTNERS, INC. is the larger business by last-quarter revenue ($199.5M vs $151.7M, roughly 1.3× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 3.6%, a 4.2% gap on every dollar of revenue. On growth, VIRTUS INVESTMENT PARTNERS, INC. posted the faster year-over-year revenue change (-4.1% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -5.7%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
VIRTUS INVESTMENT PARTNERS, INC.VRTSEarnings & Financial Report
Virtus Investment Partners, Inc. is an American company which operates as a multi-manager asset management business, comprising a number of individual affiliated managers, each having its own investment process and brand, and the services of unaffiliated sub advisers.
NUTX vs VRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $199.5M |
| Net Profit | $11.8M | $7.1M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | 7.7% |
| Net Margin | 7.8% | 3.6% |
| Revenue YoY | -41.1% | -4.1% |
| Net Profit YoY | -80.8% | -78.1% |
| EPS (diluted) | $2.34 | $1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $199.5M | ||
| Q4 25 | $151.7M | $208.0M | ||
| Q3 25 | $267.8M | $216.4M | ||
| Q2 25 | $244.0M | $210.5M | ||
| Q1 25 | $211.8M | $217.9M | ||
| Q4 24 | $257.6M | $233.5M | ||
| Q3 24 | $78.8M | $227.0M | ||
| Q2 24 | $76.1M | $224.4M |
| Q1 26 | — | $7.1M | ||
| Q4 25 | $11.8M | $33.9M | ||
| Q3 25 | $55.4M | $31.3M | ||
| Q2 25 | $-17.7M | $42.7M | ||
| Q1 25 | $21.2M | $28.1M | ||
| Q4 24 | $61.6M | $39.5M | ||
| Q3 24 | $-8.8M | $49.1M | ||
| Q2 24 | $-364.0K | $26.0M |
| Q1 26 | — | — | ||
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — |
| Q1 26 | — | 7.7% | ||
| Q4 25 | 20.4% | 19.1% | ||
| Q3 25 | 48.7% | 21.7% | ||
| Q2 25 | 13.8% | 21.5% | ||
| Q1 25 | 38.1% | 16.8% | ||
| Q4 24 | 44.4% | 21.7% | ||
| Q3 24 | 12.3% | 24.3% | ||
| Q2 24 | 7.0% | 19.7% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | 7.8% | 16.3% | ||
| Q3 25 | 20.7% | 14.5% | ||
| Q2 25 | -7.3% | 20.3% | ||
| Q1 25 | 10.0% | 12.9% | ||
| Q4 24 | 23.9% | 16.9% | ||
| Q3 24 | -11.2% | 21.6% | ||
| Q2 24 | -0.5% | 11.6% |
| Q1 26 | — | $1.05 | ||
| Q4 25 | $2.34 | $5.15 | ||
| Q3 25 | $7.76 | $4.65 | ||
| Q2 25 | $-2.95 | $6.12 | ||
| Q1 25 | $3.33 | $4.05 | ||
| Q4 24 | $11.56 | $4.65 | ||
| Q3 24 | $-1.72 | $5.71 | ||
| Q2 24 | $-0.07 | $2.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $136.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $93.6B |
| Total Assets | $918.5M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $136.6M | ||
| Q4 25 | $185.6M | — | ||
| Q3 25 | $166.0M | — | ||
| Q2 25 | $96.7M | — | ||
| Q1 25 | $84.7M | — | ||
| Q4 24 | $40.6M | — | ||
| Q3 24 | $46.9M | — | ||
| Q2 24 | $40.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | — | $231.3M | ||
| Q1 25 | — | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $247.6M |
| Q1 26 | — | $93.6B | ||
| Q4 25 | $329.4M | $934.0M | ||
| Q3 25 | $317.2M | $918.7M | ||
| Q2 25 | $235.3M | $896.4M | ||
| Q1 25 | $176.9M | $893.7M | ||
| Q4 24 | $132.4M | $897.5M | ||
| Q3 24 | $60.4M | $889.0M | ||
| Q2 24 | $62.7M | $868.7M |
| Q1 26 | — | — | ||
| Q4 25 | $918.5M | $4.3B | ||
| Q3 25 | $964.5M | $3.9B | ||
| Q2 25 | $841.0M | $3.7B | ||
| Q1 25 | $761.9M | $3.7B | ||
| Q4 24 | $655.3M | $4.0B | ||
| Q3 24 | $438.5M | $3.6B | ||
| Q2 24 | $422.4M | $3.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | — |
| Free Cash FlowOCF − Capex | $69.0M | — |
| FCF MarginFCF / Revenue | 45.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $70.4M | $-67.2M | ||
| Q3 25 | $99.5M | $108.3M | ||
| Q2 25 | $27.3M | $75.8M | ||
| Q1 25 | $51.0M | $-3.8M | ||
| Q4 24 | $54.0K | $1.8M | ||
| Q3 24 | $6.8M | $69.1M | ||
| Q2 24 | $13.3M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | $69.0M | $-74.1M | ||
| Q3 25 | $99.2M | $106.9M | ||
| Q2 25 | $26.5M | $74.2M | ||
| Q1 25 | $50.9M | $-6.8M | ||
| Q4 24 | $-341.0K | $-3.8M | ||
| Q3 24 | $6.2M | $68.7M | ||
| Q2 24 | $12.7M | $68.6M |
| Q1 26 | — | — | ||
| Q4 25 | 45.5% | -35.6% | ||
| Q3 25 | 37.0% | 49.4% | ||
| Q2 25 | 10.9% | 35.2% | ||
| Q1 25 | 24.0% | -3.1% | ||
| Q4 24 | -0.1% | -1.6% | ||
| Q3 24 | 7.8% | 30.3% | ||
| Q2 24 | 16.7% | 30.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 3.3% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.3% | 0.7% | ||
| Q1 25 | 0.0% | 1.4% | ||
| Q4 24 | 0.2% | 2.4% | ||
| Q3 24 | 0.8% | 0.2% | ||
| Q2 24 | 0.7% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 5.95× | -1.99× | ||
| Q3 25 | 1.80× | 3.45× | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | 2.40× | -0.13× | ||
| Q4 24 | 0.00× | 0.04× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
VRTS
| Investment management fees | $169.1M | 85% |
| Administration and shareholder service fees | $17.3M | 9% |
| Distribution and service fees | $11.6M | 6% |
